Clinical Trial Update: Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated combining surgical resection with Gliadel wafer implantation followed by dendritic cell vaccination in malignant glioma; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Dendritic cell vaccine
• GLIADEL wafer (carmustine)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Malignant Glioma | Phase 1 | Status: COMPLETED